Divi’s Laboratories shares came under pressure, falling more than 3% after the company’s Q1 FY26 results fell short of street expectations. As of 12:12 PM, the shares were trading 2.74% lower at Rs 6,233.50.
For the quarter ended June 30, 2025, Divi’s posted a net profit of ₹545 crore, below the CNBC-TV18 poll estimate of ₹573 crore, though it marked a 26.7% rise from ₹430 crore in Q1 FY25. Revenue from operations came in at ₹2,410 crore, up 13.8% YoY, but also shy of the expected ₹2,437 crore.
On the operational front, EBITDA stood at ₹756 crore, registering a 16.3% YoY growth, but again missed estimates pegged at ₹794.8 crore. EBITDA margin improved to 31.4% from 30.7% a year ago, though fell short of the 32.6% projection.
Sequentially, however, numbers were softer — revenue declined 6.8%, and net profit fell nearly 18% versus Q4 FY25.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
